1-9 of 9
Maria Teresa Voso
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial

Clinical Trials & Observations
Adriano Venditti, Alfonso Piciocchi, Anna Candoni, Valentina Arena, Raffaele Palmieri, Carla Filì, Angelo Michele Carella, Valeria Calafiore, Roberto Cairoli, Paolo de Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Antonio Curti, Mario Luppi, Claudia Ingrosso, Maria Paola Martelli, Antonio Cuneo, Francesco Albano, Antonino Mulè, Agostino Tafuri, Laura Cudillo, Alessia Tieghi, Nicola Stefano Fracchiolla, Debora Capelli, Silvia Maria Trisolini, Caterina Alati, Edoardo La Sala, Luca Maurillo, Maria Ilaria Del Principe, Maria Antonietta Irno Consalvo, Maria Domenica Divona, Tiziana Ottone, Raffaella Cerretti, Giuseppe Sconocchia, Maria Teresa Voso, Paola Fazi, Marco Vignetti, Francesco Buccisano
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4410–4413.
https://doi.org/10.1182/bloodadvances.2024013182
Published: 2024
Includes: Supplemental data
Journal Articles

Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT

Carmelo Gurnari, Linda Koster, Laurien Baaij, Mael Heiblig, Ibrahim Yakoub-Agha, Matthew Collin, Jakob Passweg, Claude E. Bulabois, Anjum Khan, Michael Loschi, Fabrizio Carnevale-Schianca, Elena Crisà, Daniela Caravelli, Jürgen Kuball, Francesco Saraceni, Attilio Olivieri, Alessandro Rambaldi, Austin G. Kulasekararaj, Patrick J. Hayden, Manuela Badoglio, Francesco Onida, Christof Scheid, Franco Franceschini, Arsène Mekinian, Sinisa Savic, Maria Teresa Voso, Joanna Drozd-Sokolowska, John A Snowden, Kavita Raj, Tobias Alexander, Marie Robin, Raffaella Greco, Donal P. McLornan
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1444–1448.
https://doi.org/10.1182/bloodadvances.2023012478
Published: 2024
Includes: Supplemental data
Journal Articles

Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting

Enrico Attardi, Arianna Savi, Beatrice Borsellino, Alfonso Piciocchi, Marta Cipriani, Tiziana Ottone, Emiliano Fabiani, Mariadomenica Divona, Serena Travaglini, Maria Rosaria Pascale, Hussein Awada, Arda Durmaz, Valeria Visconte, Matteo Giovanni Della Porta, Adriano Venditti, Jaroslaw P. Maciejewski, Carmelo Gurnari, Maria Teresa Voso
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5122–5131.
https://doi.org/10.1182/bloodadvances.2023010173
Published: 2023
Includes: Supplemental data
Journal Articles

ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol

Clinical Trials & Observations
Francesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, Valentina Arena, Anna Candoni, Lorella Melillo, Valeria Calafiore, Roberto Cairoli, Paolo de Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Mario Luppi, Saveria Capria, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Maria Antonietta Irno Consalvo, Tiziana Ottone, Serena Lavorgna, Maria Teresa Voso, Paola Fazi, Marco Vignetti, William Arcese, Adriano Venditti
Journal: Blood Advances
Blood Adv (2022) 6 (8): 2510–2516.
https://doi.org/10.1182/bloodadvances.2021005717
Published: 2022
Includes: Supplemental data
Journal Articles

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML

Clinical Trials & Observations
Amer M. Zeidan, Isaac Boss, C. L. Beach, Wilbert B. Copeland, Ethan Thompson, Brian A. Fox, Vanessa E. Hasle, Andrzej Hellmann, David C. Taussig, Mar Tormo, Maria Teresa Voso, James Cavenagh, Tim O’Connor, Alessandro Previtali, Shelonitda Rose, Lewis R. Silverman
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2219–2229.
https://doi.org/10.1182/bloodadvances.2021006138
Published: 2022
Includes: Supplemental data
Journal Articles

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromes

Clinical Trials & Observations
Amer M. Zeidan, Isaac Boss, C. L. Beach, Wilbert B. Copeland, Ethan Thompson, Brian A. Fox, Vanessa E. Hasle, Ken Ogasawara, James Cavenagh, Lewis R. Silverman, Maria Teresa Voso, Andrzej Hellmann, Mar Tormo, Tim O’Connor, Alessandro Previtali, Shelonitda Rose, Guillermo Garcia-Manero
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2207–2218.
https://doi.org/10.1182/bloodadvances.2021005487
Published: 2022
Includes: Supplemental data
Journal Articles

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy

Clinical Trials & Observations
Fabio Efficace, Uwe Platzbecker, Massimo Breccia, Francesco Cottone, Paola Carluccio, Prassede Salutari, Eros Di Bona, Erika Borlenghi, Francesco Autore, Luciano Levato, Olimpia Finizio, Valentina Mancini, Stefano D’Ardia, Richard F. Schlenk, Lorella Melillo, Monica Fumagalli, Walter Fiedler, Germana Beltrami, Nicola Stefano Fracchiolla, Massimo Bernardi, Paola Fazi, Ombretta Annibali, Karin Mayer, Maria Teresa Voso, Marco Vignetti
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4370–4379.
https://doi.org/10.1182/bloodadvances.2021004649
Published: 2021
Includes: Supplemental data
Journal Articles

Midostaurin in patients with acute myeloid leukemia and FLT3 -TKD mutations: a subanalysis from the RATIFY trial

Clinical Trials & Observations
Maria Teresa Voso, Richard A. Larson, Dan Jones, Guido Marcucci, Thomas Prior, Jürgen Krauter, Michael Heuser, Serena Lavorgna, Josep Nomdedeu, Susan M. Geyer, Alison Walker, Andrew H. Wei, Jorge Sierra, Miguel A. Sanz, Joseph M. Brandwein, Theo M. de Witte, Joop H. Jansen, Dietger Niederwieser, Frederick R. Appelbaum, Bruno C. Medeiros, Martin S. Tallman, Richard F. Schlenk, Arnold Ganser, Sergio Amadori, Yuan Cheng, YinMiao Chen, Celine Pallaud, Ling Du, Alfonso Piciocchi, Gerhard Ehninger, John Byrd, Christian Thiede, Konstanze Döhner, Richard M. Stone, Hartmut Döhner, Clara D. Bloomfield, Francesco Lo-Coco
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4945–4954.
https://doi.org/10.1182/bloodadvances.2020002904
Published: 2020
Includes: Supplemental data
Journal Articles

Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD + AML

Silvia Masciarelli, Ernestina Capuano, Tiziana Ottone, Mariadomenica Divona, Serena Lavorgna, Francesca Liccardo, Martyna Śniegocka, Serena Travaglini, Nelida I. Noguera, Alessandra Picardi, Vincenzo Petrozza, Alessandro Fatica, Luca Tamagnone, Maria Teresa Voso, Francesco Lo Coco, Francesco Fazi
Journal: Blood Advances
Blood Adv (2019) 3 (24): 4155–4160.
https://doi.org/10.1182/bloodadvances.2019000540
Published: 2019
Includes: Supplemental data